AKT1 and glioblastoma: Glycogen synthase kinase-3β (GSK-3β) and p53, protein substrates downstream of the PI3K/Akt pathway, also regulate cellular sensitivity/resistance to cancer chemotherapy and are unregulated in glioblastoma multiform [6,7].